Nexperia B.V. has issued an important update regarding recent developments that are impacting its global operations, governance structure, and supply chain. The company affirms its commitment to transparency, business continuity, and the interests of its global customers, suppliers, employees, and stakeholders.

Nexperia welcomed the one-year suspension by U.S. authorities of the “Affiliate Rule,” which had previously extended U.S. export control restrictions to companies owned 50 percent or more by entities listed on the U.S. Entity List. This rule had potential implications for Nexperia as a wholly owned subsidiary of Wingtech Technology Co., Ltd., which was added to the U.S. BIS Entity List in December 2024.

The company also acknowledged China’s renewed commitment to facilitating the resumption of exports from both Nexperia’s Chinese manufacturing site and its subcontractors. This step will help restore the supply of critical legacy semiconductors to global markets. Nexperia is awaiting further clarification on the procedures and criteria related to this easing of export restrictions.

Despite these positive developments, Nexperia reported that certain corporate governance protocols have not been followed within its Chinese entities. As of October 13, Nexperia B.V. no longer has oversight of product shipments from its facility in China. Due to this lack of transparency, the company cannot guarantee the authenticity, intellectual property compliance, or quality of any products manufactured or shipped from that site.

On October 29, 2025, Nexperia B.V. suspended direct wafer shipments to its China facility after payment for prior shipments was refused. This action followed a series of concerning events, including:

  • Misappropriation of corporate seals without valid explanation
  • Creation of unauthorized bank accounts and diversion of customer payments
  • Distribution of unauthorized communications containing inaccurate information to customers, suppliers, and employees

In response, Nexperia has mobilized dedicated teams to establish alternative supply chain solutions aimed at minimizing disruption and maintaining product availability. While shipments to the Chinese facility have been suspended, wafer supply from other Nexperia sites in Europe and Asia continues without interruption.

All products manufactured outside of China are produced using genuine Nexperia wafers and materials, and adhere to the company’s established quality standards and intellectual property rights. These products remain fully compliant and continue to be delivered to customers worldwide.

Nexperia reaffirmed its long-term commitment to China and to its local employees, noting that its manufacturing operations in Dongguan remain a core component of its strategic roadmap. The company remains hopeful for a resolution and a return to normal operations.

In response to recent media speculation, Nexperia confirmed that Zhang Xuezheng (Wing) has been suspended from his role as CEO and as a director of the company, as mandated by the Dutch Enterprise Chamber ruling on October 7, 2025. He is no longer acting in any executive capacity at Nexperia.

Furthermore, the ruling placed substantially all voting rights of the shares in Nexperia—indirectly held by Wingtech—under the authority of an independent administrator. Any contrary claims are inaccurate.

Nexperia continues to comply fully with the Dutch government’s protection order, which remains in place for up to one year. While it imposes restrictions on major structural changes—such as relocations or executive dismissals—it does not interfere with normal business operations or production capacity, particularly as it relates to European interests.

Nexperia will continue to provide updates as the situation evolves. The company encourages its partners and customers to reach out directly with questions or to verify any external communications received.

Original – Nexperia